Cancer feature: cnaPANCAN210

AADAT ACSL1 ADAM29 AGA ANKRD37 ANXA10 ASB5 C4orf27 C4orf45 C4orf46 C4orf47 CASP3 CBR4 CCDC110 CDKN2AIP CENPU CEP44 CLCN3 CLDN22 CLDN24 CPE CYP4V2 DCTD DDX60 DDX60L ENPP6 ETFDH F11 FAM149A FAM198B FAM218A FAT1 FBXO8 FNIP2 FSTL5 GALNT7 GALNTL6 GLRA3 GLRB GPM6A GRIA2 HAND2 HELT HMGB2 HPGD ING2 IRF2 KIAA1430 KLHL2 KLKB1 LINC01098 LRP2BP MARCH1 MFAP3L MSMO1 MTNR1A NAF1 NEIL3 NEK1 NPY1R NPY5R PALLD PDGFC PDLIM3 PPID PRIMPOL RAPGEF2 RP11-171N4.2 RP11-215A19.2 RP11-279O9.4 RP11-487E13.1 RP11-701P16.2 RWDD4 RXFP1 SAP30 SCRG1 SH3RF1 SLC25A4 SNX25 SORBS2 SPATA4 SPCS3 SPOCK3 STOX2 TENM3 TKTL2 TLL1 TLR3 TMA16 TMEM144 TMEM192 TRAPPC11 TRIM60 TRIM61 UFSP2 VEGFC WDR17 WWC2

Known Driver Genes: None

Copy number alternation: loss

Uprosertib

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer